To further confirm the clinical significance of DDX17 expression in HBV-related HCC, we recruited 24 patients diagnosed with HBV-related HCC in this study and divided them into two groups based on their metastatic status (metastatic and nonmetastatic groups). Here, DDX17 is linked to hepatocellular carcinoma.